Skip to Main Content

Paper Details

The VCAM1-ApoE pathway directs microglial chemotaxis and alleviates Alzheimer's disease pathology.
1
2023
AD, Alzheimer's disease, ApoE, DAMP, IL-33, VCAM1, amyloid, amyloid-beta (A), interleukin-33, microglia, microglial, microglial A, patients, sensome receptor
Author NameAffiliation
David M HoltzmanHope Center for Neurological Disorders, Charles F. and Joanne Knight Alzheimer's Disease Research Center, Washington University School of Medicine
  • 1 - 1

Datasets

Release 1.2